Obesity and nonadherence correlate with elevated serum estradiol levels in postmenopausal women receiving adjuvant aromatase inhibitor therapy

Breast J. 2014 Sep-Oct;20(5):553-4. doi: 10.1111/tbj.12324. Epub 2014 Aug 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Aromatase Inhibitors / therapeutic use*
  • Breast Neoplasms / blood
  • Breast Neoplasms / complications
  • Breast Neoplasms / drug therapy*
  • Estradiol / blood
  • Female
  • Florida
  • Humans
  • Middle Aged
  • Obesity / complications*
  • Patient Compliance*
  • Postmenopause*

Substances

  • Aromatase Inhibitors
  • Estradiol